Robert W. Shaw's most recent trade in Ultralife Corp was a trade of 1,750 Common Stock; $.10 par value done at an average price of $5.7 . Disclosure was reported to the exchange on Nov. 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ultralife Corp | Robert W. Shaw | Director | Purchase of securities on an exchange or from another person at price $ 5.67 per share. | 24 Nov 2025 | 1,750 | 71,000 (0%) | 0% | 5.7 | 9,923 | Common Stock; $.10 par value |
| Ultralife Corp | Robert W. Shaw | Director | Purchase of securities on an exchange or from another person at price $ 5.49 per share. | 14 May 2025 | 4,000 | 69,250 (0%) | 0% | 5.5 | 21,960 | Common Stock; $.10 par value |
| Ultralife Corp | Robert W. Shaw | Director | Purchase of securities on an exchange or from another person at price $ 7.91 per share. | 12 Nov 2024 | 2,500 | 65,250 (0%) | 0% | 7.9 | 19,775 | Common Stock; $.10 par value |
| Ultralife Corp | Robert W. Shaw | Director | Purchase of securities on an exchange or from another person at price $ 5.10 per share. | 07 Feb 2022 | 3,000 | 60,750 (0%) | 0% | 5.1 | 15,300 | Common Stock; $.10 par value |